These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 4350284

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE, Giraudo Conesa LC, Braun M.
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epstein-barr-virus nuclear antigen.
    Vonka V, Hirsch I.
    Prog Med Virol; 1982 Mar; 28():145-79. PubMed ID: 6283600
    [No Abstract] [Full Text] [Related]

  • 6. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W, Henle G.
    Ann Clin Lab Sci; 1974 Mar; 4(2):109-14. PubMed ID: 4362218
    [No Abstract] [Full Text] [Related]

  • 7. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups.
    Ida S, Sairenji T, Hinuma Y.
    Gan; 1972 Feb; 63(1):49-55. PubMed ID: 4339712
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
    Banatvala JE, Best JM, Waller DK.
    Lancet; 1972 Jun 03; 1(7762):1205-8. PubMed ID: 4113190
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G, Hewetson J, Henle W.
    Int J Cancer; 1973 May 03; 11(3):637-47. PubMed ID: 4364719
    [No Abstract] [Full Text] [Related]

  • 14. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS, Hewetson JF.
    Int J Cancer; 1974 Oct 15; 14(4):530-8. PubMed ID: 4376526
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
    Henle W, Henle G.
    Laryngoscope; 1977 Apr 15; 87(4 Pt 1):467-73. PubMed ID: 190497
    [Abstract] [Full Text] [Related]

  • 19. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P.
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972 Apr 15; 65(9):228-32. PubMed ID: 4353758
    [No Abstract] [Full Text] [Related]

  • 20. The Epstein-Barr virus: historical, biologic, pathologic and oncologic considerations.
    Seemayer TA, Oligny LL, Gartner JG.
    Perspect Pediatr Pathol; 1981 Apr 15; 6():1-33. PubMed ID: 6275338
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.